Stroke: working toward a prioritized world agenda

  1. Vladimir Hachinski1,
  2. Geoffrey A. Donnan2,
  3. Philip B. Gorelick3,
  4. Werner Hacke4,
  5. Steven C. Cramer5,
  6. Markku Kaste6,
  7. Marc Fisher7,
  8. Michael Brainin8,
  9. Alastair M. Buchan9,
  10. Eng H. Lo10,
  11. Brett E. Skolnick11,
  12. Karen L. Furie10,
  13. Graeme J. Hankey12,
  14. Miia Kivipelto13,
  15. John Morris14,
  16. Peter M. Rothwell15,
  17. Ralph L. Sacco16,
  18. Sidney C. Smith, Jr17,
  19. Yulun Wang18,
  20. Alan Bryer19,
  21. Gary A. Ford20,
  22. Costantino Iadecola21,
  23. Sheila C.O. Martins22,
  24. Jeff Saver23,
  25. Veronika Skvortsova24,
  26. Mark Bayley25,
  27. Martin M. Bednar26,
  28. Pamela Duncan27,
  29. Lori Enney28,
  30. Seth Finklestein29,
  31. Theresa A. Jones30,
  32. Lalit Kalra31,
  33. Jeff Kleim32,
  34. Ralph Nitkin33,
  35. Robert Teasell34,
  36. Cornelius Weiller35,
  37. Bhupat Desai36,
  38. Mark P. Goldberg14,
  39. Wolf-Dieter Heiss37,
  40. Osmo Saarelma38,
  41. Lee H. Schwamm10,
  42. Yukito Shinohara39,
  43. Bhargava Trivedi40,
  44. Nils Wahlgren41,
  45. Lawrence K. Wong42,
  46. Antoine Hakim43,
  47. Bo Norrving44,
  48. Stephen Prudhomme45,
  49. Natan M. Bornstein46,
  50. Stephen M. Davis47,
  51. Larry B. Goldstein48,
  52. Didier Leys49,
  53. Jaakko Tuomilehto50

Article first published online: 6 JUL 2010

DOI: 10.1111/j.1747-4949.2010.00442.x

Issue

International Journal of Stroke

International Journal of Stroke

Volume 5, Issue 4, pages 238–256, August 2010

Additional Information

How to Cite

Hachinski, V., Donnan, G. A., Gorelick, P. B., Hacke, W., Cramer, S. C., Kaste, M., Fisher, M., Brainin, M., Buchan, A. M., Lo, E. H., Skolnick, B. E., Furie, K. L., Hankey, G. J., Kivipelto, M., Morris, J., Rothwell, P. M., Sacco, R. L., Smith, Jr, S. C., Wang, Y., Bryer, A., Ford, G. A., Iadecola, C., Martins, S. C.O., Saver, J., Skvortsova, V., Bayley, M., Bednar, M. M., Duncan, P., Enney, L., Finklestein, S., Jones, T. A., Kalra, L., Kleim, J., Nitkin, R., Teasell, R., Weiller, C., Desai, B., Goldberg, M. P., Heiss, W.-D., Saarelma, O., Schwamm, L. H., Shinohara, Y., Trivedi, B., Wahlgren, N., Wong, L. K., Hakim, A., Norrving, B., Prudhomme, S., Bornstein, N. M., Davis, S. M., Goldstein, L. B., Leys, D. and Tuomilehto, J. (2010), Stroke: working toward a prioritized world agenda. International Journal of Stroke, 5: 238–256. doi: 10.1111/j.1747-4949.2010.00442.x

Author Information

  1. 1

    Department of Clinical Neurological Sciences, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada

  2. 2

    Florey Neurosciences Institutes, Carlton South Victoria, Australia

  3. 3

    University of Illinois at Chicago, Chicago, Ill

  4. 4

    University of Heidelberg, Heidelberg, Germany

  5. 5

    University of California–Irvine, Orange, Calif

  6. 6

    Helsinki University Central Hospital (5*), University of Helsinki; Helsinki, Finland

  7. 7

    University of Massachusetts Medical School, Worcester, Mass

  8. 8

    University Donau-Universität Krems (7*), Krems, Austria

  9. 9

    University of Oxford, Oxford, UK

  10. 10

    Massachusetts General Hospital, Charlestown, Mass

  11. 11

    Novo Nordisk, Princeton, NJ

  12. 12

    Royal Perth Hospital, Perth, Australia

  13. 13

    Karolinska Institute (2), Stockholm, Sweden

  14. 14

    Washington University School of Medicine, St. Louis, MO

  15. 15

    John Radcliffe Hospital, Oxford, UK

  16. 16

    President-elect, AHA, University of Miami, Miami, Fla

  17. 17

    University of North Carolina, Center for Cardiovascular Science and Medicine, Chapel Hill, NC, and President-elect, World Heart Federation, Geneva, Switzerland

  18. 18

    InTouch Health, Goleta, Calif

  19. 19

    Groote Schuur Hospital and University of Cape Town (UCT;), Cape Town, South Africa

  20. 20

    Newcastle University, Newcastle Upon Tyne, UK

  21. 21

    Weill Cornell Medical College, New York, NY

  22. 22

    Hospital De Clinicas, Porto Alegre, Brazil

  23. 23

    University of California at Los Angeles Stroke Center, Los Angeles, Calif

  24. 24

    Russian State Research Stroke Institute, Moscow, Russian Federation

  25. 25

    Toronto Rehabilitation Institute (4), Toronto, Ontario, Canada

  26. 26

    Neuroscience Research Unit, Pfizer Inc, Groton, Conn

  27. 27

    Duke University, Durham, NC

  28. 28

    GlaxoSmithKline, Durham, NC

  29. 29

    Biotrofix, Inc, Waltham, Mass

  30. 30

    University of Texas at Austin, Austin, Texas

  31. 31

    Kings College London, London, UK

  32. 32

    University of Florida, Gainesville, Fla

  33. 33

    National Center for Medical Rehabilitation/National Institute of Child Health and Human Development/National Institutes of Health, Rockville, Md

  34. 34

    St Joseph's Healthcare London, London, Ontario, Canada

  35. 35

    University of Freiburg, Freiburg, Germany

  36. 36

    Pomona Valley Hospital Medical Center, Pomona, Calif

  37. 37

    Max Planck Institute for Neurological Research, Koln, Germany

  38. 38

    Terveystalo Medical Center, Helsinki, Finland

  39. 39

    Tachikawa Hospital, Tokyo, Japan

  40. 40

    Southern Illinois Healthcare, Carbondale, Ill

  41. 41

    Karolinska Institute, Stockholm, Sweden

  42. 42

    Chinese University of Hong Kong, Sha Tin, Hong Kong, China

  43. 43

    The Canadian Stroke Network, the University of Ottawa and the Ottawa Hospital Research Institute; Ottawa, Ontario, Canada

  44. 44

    Lund University Hospital, Lund, Sweden

  45. 45

    American Heart Association, Dallas, Texas

  46. 46

    Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel

  47. 47

    Director of Neurology, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia

  48. 48

    Duke University and Durham VA Medical Center, Durham, NC

  49. 49

    University Lille Nord de France, Lille, France

  50. 50

    University of Helsinki, Helsinki, Finland.

* Vladimir Hachinski, MD, FRCPC, DSc, University of Western Ontario, University Hospital, 339 Windermere Road, London, Ontario, Canada N6A 5A5. E-mail Vladimir.Hachinski@lhsc.on.ca

  1. From the Department of Clinical Neurological Sciences (V.H.), London Health Sciences Center, University of Western Ontario, London, Ontario, Canada; Florey Neurosciences Institutes (G.A.D.), Carlton South Victoria, Australia; University of Illinois at Chicago (P.B.G.), Chicago, Ill; University of Heidelberg (W.H.), Heidelberg, Germany; University of California–Irvine (S.C.C.), Orange, Calif; Helsinki University Central Hospital (M.K.5*), University of Helsinki; Helsinki, Finland; University of Massachusetts Medical School (M.F.), Worcester, Mass; University Donau-Universität Krems (M.B.7*), Krems, Austria; University of Oxford (A.M.B.), Oxford, UK; Massachusetts General Hospital (E.H.L., K.L.F., L.H.S.), Charlestown, Mass; Novo Nordisk (B.E.S.), Princeton, NJ; Royal Perth Hospital (G.J.H.), Perth, Australia; Karolinska Institute (M.K.2), Stockholm, Sweden; Washington University School of Medicine (J.M., M.P.G.), St. Louis, MO; John Radcliffe Hospital (P.M.R.), Oxford, UK; President-elect, AHA, University of Miami (R.L.S.), Miami, Fla; University of North Carolina (S.C.S.), Center for Cardiovascular Science and Medicine, Chapel Hill, NC, and President-elect, World Heart Federation, Geneva, Switzerland; InTouch Health (Y.W.), Goleta, Calif; Groote Schuur Hospital and University of Cape Town (UCT; A.B.), Cape Town, South Africa; Newcastle University (G.A.F.), Newcastle Upon Tyne, UK; Weill Cornell Medical College (C.I.), New York, NY; Hospital De Clinicas (S.C.O.M.), Porto Alegre, Brazil; University of California at Los Angeles Stroke Center (J.S.), Los Angeles, Calif; Russian State Research Stroke Institute (V.S.), Moscow, Russian Federation; Toronto Rehabilitation Institute (M.B.4), Toronto, Ontario, Canada; Neuroscience Research Unit (M.M.B.), Pfizer Inc, Groton, Conn; Duke University (P.D.), Durham, NC; GlaxoSmithKline (L.E.), Durham, NC; Biotrofix, Inc (S.F.), Waltham, Mass; University of Texas at Austin (T.A.J.), Austin, Texas; Kings College London (L.K.), London, UK; University of Florida (J.K.), Gainesville, Fla; National Center for Medical Rehabilitation/National Institute of Child Health and Human Development/National Institutes of Health (R.N.), Rockville, Md; St Joseph's Healthcare London (R.T.), London, Ontario, Canada; University of Freiburg (C.W.), Freiburg, Germany; Pomona Valley Hospital Medical Center (B.D.), Pomona, Calif; Max Planck Institute for Neurological Research (W.-D.H.), Koln, Germany; Terveystalo Medical Center (O.S.), Helsinki, Finland; Tachikawa Hospital (Y.S.), Tokyo, Japan; Southern Illinois Healthcare (B.T.), Carbondale, Ill; Karolinska Institute (N.W.), Stockholm, Sweden; Chinese University of Hong Kong (L.K.W.), Sha Tin, Hong Kong, China; The Canadian Stroke Network (A.H.), the University of Ottawa and the Ottawa Hospital Research Institute; Ottawa, Ontario, Canada; Lund University Hospital (B.N.), Lund, Sweden; American Heart Association (S.P.), Dallas, Texas; Tel Aviv Sourasky Medical Center (N.M.B.), Tel Aviv University, Tel Aviv, Israel; Director of Neurology (S.M.D.), Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia; Duke University and Durham VA Medical Center (L.B.G.), Durham, NC; University Lille Nord de France (D.L.), Lille, France; and the University of Helsinki (J.T.), Helsinki, Finland.

  2. The numerical suffix with the names indicates the various groups. The coordinator of each group is indicated by an asterisk. The work of the coordinators is deemed to have been equal. The other authors are listed according to the sequence of their groups and alphabetically, and their work is also deemed to be equal to each other's.

  3. Working Groups: (1) Basic Science, Drug Development, and Technology; (2) Stroke Prevention: Broadening the Approach and Intensifying the Efforts; (3) Acute Stroke Management: Applying and Expanding What We Know; (4) Brain Recovery and Rehabilitation: Harnessing the Regenerative Powers of the Brain and the Individual; (5) Into the 21st Century: The Web, Technology, and Communications: New Tools for Progress; (6) Fostering Cooperation Among Stakeholders to Enhance Stroke Care; and (7). Educating and Energizing Professionals, Patients, the Public, and Policymakers.

  4. This article has been co-published in: Stroke. June 2010; Vol 41, Issue 6, Cerebrovascular Diseases. July 2010; Vol 30, Issue 2 and International Journal of Stroke. August 2010; Vol 5, Issue 4.

Publication History

  1. Issue published online: 6 JUL 2010
  2. Article first published online: 6 JUL 2010
  3. Received and accepted April 12, 2010.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (414K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (414K)